Physician profile
Stephen P Beals
NPI 1134179336
$39,842.22
in general payments reported to CMS, 2019-2025
8 companies · $2,338 in 2025
The $2,338 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $788 · 2021: $5,267 · 2022: $5,085 · 2023: $19K · 2024: $7,061 · 2025: $2,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,744 · Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $20,298.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,744.20 |
| Food and Beverage | $1,018.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $27,064.65 | 2019-2025 | Cmf |
| Abbvie INC. | $6,032.47 | 2023-2025 | Botox |
| Allergan, INC. | $6,014.82 | 2019-2023 | |
| Musculoskeletal Transplant Foundation INC. | $210.23 | 2023 | |
| Revance Therapeutics, INC. | $187.31 | 2024-2025 | Daxxify |
| Mentor Worldwide LLC | $181.15 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $121.18 | 2019-2023 | |
| Sientra, INC. | $30.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Beals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.